Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 22, 2006

University of Glasgow Genomics Facility Selects GenoLogics for Systems Biology

  • GenoLogics Life Sciences Software reported that the University of Glasgow’s Sir Henry Wellcome Functional Genomics Facility (SHWFGF) recently installed GenoLogics’ Proteus solution for their proteomics research and will be adding the Geneus solution for genomics research projects in the near future.

    GenoLogics will provide the Sir Henry Wellcome Functional Genomics Facility and the RASOR Interdisciplinary Research Collaboration with a solution for systems biology that enables a cross-science approach to genomics and proteomics research.

    Andrew Pitt, Ph.D., director of the Sir Henry Wellcome Functional Genomics Facility and RASOR, stated, “We chose GenoLogics because of its partnering philosophy and commitment to systems biology and open standards, as well as its ability to customize a cross-science solution combining genomics and proteomics, with the promise of further developments in new fields. This will greatly enhance the productivity of the SHWFGF and our RASOR initiative.

    “I’m increasingly convinced that it is crucial that software and database informatics technologies complement and accelerate the use of proteomics and genomics instrumentation and technologies in order to make research advances. The GenoLogics solution integrates with our instruments and allows flexible workflows, which frees our researchers to focus on science rather than data-management issues.”



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »